CD19 and melanoma: However, neither B cell- (CD19-cre) (Rickert et al., 1997) nor macrophage-specific (LysM-cre) (Clausen et al., 1999) H2-Aa KO resulted in inhibition of B16F10 melanoma growth (Fig. 2, D and E).